The Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market encompasses the development and provision of medical treatments aimed at managing and alleviating symptoms of ITP, a disorder characterized by low platelet counts leading to excessive bruising and bleeding. This market includes corticosteroids, immunoglobulins, thrombopoietin receptor agonists, and emerging therapies, a... https://www.globalinsightservices.com/reports/idiopathic-thrombocytopenic-purpura-therapeutics-market